Dapivirine Ring Early Introduction Considerations — Zimbabwe Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Zimbabwe was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For analysis on all the selected countries, click here.) Interviews comprised a mix of policymakers, civil society representatives, donors, implementing partners and trial contributors.